Skip to main content
. 2021 Feb 5;5(3):823–828. doi: 10.1182/bloodadvances.2020002910

Table 3.

Frequency of most common TEAEs (occurring in ≥10% of the population)

Any grade (n = 23) Grade 3/4 (n = 23)
Any TEAE, n (%) 23 (100) 19 (82.3)
 Fatigue 12 (52.2) 3 (13.0)
 Diarrhea 11 (47.8) 3 (13.0)
 Hyperglycemia 11 (47.8) 9 (39.1)
 Hypertension 10 (43.5) 9 (39.1)
 Nausea 6 (26.1) 0
 Neutropenia 6 (26.1) 3 (13.0)
 Pruritus 6 (26.1) 0
 Anemia 5 (21.7) 1 (4.3)
 Cough 5 (21.7) 0
 Pyrexia 5 (21.7) 1 (4.3)
 Upper abdominal pain 5 (21.7) 0
 Constipation 4 (17.4) 0
 Pneumonia 4 (17.4) 3 (13.0)
 Arthralgia 3 (13.0) 0
 Dizziness 3 (13.0) 0
 Insomnia 3 (13.0) 0
 Maculopapular rash 3 (13.0) 0
 Muscle spasms 3 (13.0) 1 (4.3)
 Oropharyngeal pain 3 (13.0) 0
 Upper respiratory infection 3 (13.0) 1 (4.3)
 Vomiting 3 (13.0) 0

TEAEs were coded according to the Medical Dictionary for Regulatory Activities.